Researchers have tested an artificial pancreas that could one day improve lives of millions of people suffering from diabetes in a home environment for the first time.
Blood glucose levels are monitored by the device, which uses an infrared data link to relay info to an insulin pump attached to the patient's body, which adjusts insulin levels accordingly.
Researchers at the University of Cambridge have been working on the artificial pancreas for many years and by the end of this year, 24 people will have taken part in home trials, the Independent reported.
However, the device still has a long way before it is commonly available as a treatment for Type 1 diabetes, and will initially be used only to stop people's insulin levels from falling too low at night.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
